Pipeline
Internal Programs
Programs
Targets
Indication
Preclinical
PHASE 1
Milestones
Partners
UB-VV200
Multiple
Solid Tumors
Preclinical
PHASE 1
IND enabling
UB-VV300/310
CD20
NHL/Autoimmune
Preclinical
PHASE 1
IND enabling
UB-VV400/410
CD22
NHL/Autoimmune
Preclinical
PHASE 1
Clinic 2024
UB-VV500
Undisclosed
Multiple Myeloma
Preclinical
PHASE 1
IND enabling
Partnered Programs
Programs
Targets
Indication
Preclinical
PHASE 1
Milestones
Partners
UB-VV111
CD19
Hematology
Preclinical
PHASE 1
Clinic 2024
Multiple
Undisclosed
Hematology
Preclinical
PHASE 1
Early development
Multiple
Undisclosed
Oncology
Preclinical
PHASE 1
Early development
TumorTag Programs
Programs
Targets
Indication
Preclinical
PHASE 1
Milestones
Partners
UB-TT440
PSMA
Solid Tumors
Preclinical
PHASE 1
Early development
Undisclosed
CA IX
Solid Tumors
Preclinical
PHASE 1
Early development
Undisclosed
FAP
Solid Tumors
Preclinical
PHASE 1
Early development
